Arrowhead Research Corporation (ARWR) is a publicly traded Healthcare sector company. As of May 20, 2026, ARWR trades at $77.11 with a market cap of $10.42B and a P/E ratio of -35.25. ARWR moved +5.35% today. Year to date, ARWR is +7.95%; over the trailing twelve months it is +364.93%. Its 52-week range spans $9.57 to $82.26. Analyst consensus is strong buy with an average price target of $89.25. Rallies surfaces ARWR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Arrowhead Research Corporation (ARWR) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ARWR moved +5.35% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $77.11 |
| Market Cap | $10.42B |
| P/E Ratio | -35.25 |
| EPS | $-2.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $82.26 |
| 52-Week Low | $9.57 |
| Volume | 1.25M |
| Avg Volume | 0 |
| Revenue (TTM) | $622.01M |
| Net Income | $-271.86M |
| Gross Margin | 0.00% |
10 analysts cover ARWR: 0 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $89.25.